Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-14 Sale | 2024-06-18 5:58 pm | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 63,358 | $46.57 | $2,950,518 | 308,403 (Direct) | View |
| 2022-08-10 Purchase | 2022-08-11 09:55 am | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 3,800 | $0.264 | $1,003 | 98,230 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-16 10:41 am | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 10,500 | $0.25 | $2,625 | 94,430 (Direct) | View |
| 2022-03-09 Purchase | 2022-03-09 10:37 am | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 8,600 | $0.37 | $3,182 | 83,930 (Direct) | View |
| 2020-11-11 Purchase | 2020-11-12 10:28 am | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 4,240 | $1.209 | $5,126 | 75,330 (Direct) | View |
| 2020-03-17 Purchase | 2020-03-17 1:14 pm | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 4,300 | $3.49 | $15,007 | 71,090 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Exercise | 2024-06-18 5:58 pm | 2023-02-01 2032-02-01 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 56,179 | $0 | 308,403 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 5:58 pm | N/A N/A | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 16,579 | $4.26 | 308,403 (Direct) | View |
| 2024-06-17 Exercise | 2024-06-18 5:58 pm | N/A N/A | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 21,000 | $30 | 308,403 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 5:58 pm | N/A N/A | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 18,600 | $14.1 | 308,403 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 3:19 pm | N/A 2034-02-12 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 73,947 | $0 | 158,347 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-30 4:56 pm | 2014-02-28 2014-01-29 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 7,179 | $4.97 | 7,179 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 12:44 pm | N/A 2033-02-13 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 1,989,546 | $0 | 1,949,546 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:51 pm | N/A 2032-02-01 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 1,489,700 | $0 | 1,489,700 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-04 4:35 pm | N/A 2031-02-02 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 1,913,000 | $0 | 1,913,000 (Direct) | View |
| 2020-03-06 Option Award | 2020-03-09 5:31 pm | N/A 2030-03-06 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer | 639,000 | $0 | 639,000 (Direct) | View |